These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17584802)

  • 1. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum.
    Bucki R; Sostarecz AG; Byfield FJ; Savage PB; Janmey PA
    J Antimicrob Chemother; 2007 Sep; 60(3):535-45. PubMed ID: 17584802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.
    Leszczyńska K; Namiot A; Cruz K; Byfield FJ; Won E; Mendez G; Sokołowski W; Savage PB; Bucki R; Janmey PA
    J Appl Microbiol; 2011 Jan; 110(1):229-38. PubMed ID: 20961363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin.
    Weiner DJ; Bucki R; Janmey PA
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):738-45. PubMed ID: 12600826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis.
    Alipour M; Suntres ZE; Halwani M; Azghani AO; Omri A
    PLoS One; 2009 May; 4(5):e5724. PubMed ID: 19479000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.
    Wnorowska U; Niemirowicz K; Myint M; Diamond SL; Wróblewska M; Savage PB; Janmey PA; Bucki R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3808-15. PubMed ID: 25870055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic amphiphiles increase activity of aminoglycoside antibiotic tobramycin in the presence of airway polyelectrolytes.
    Purdy Drew KR; Sanders LK; Culumber ZW; Zribi O; Wong GC
    J Am Chem Soc; 2009 Jan; 131(2):486-93. PubMed ID: 19072156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteria.
    Isogai E; Isogai H; Takahashi K; Okumura K; Savage PB
    Oral Microbiol Immunol; 2009 Apr; 24(2):170-2. PubMed ID: 19239645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
    Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
    Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Guzel C; Savage PB; Gerceker AA
    Chemotherapy; 2011; 57(6):505-10. PubMed ID: 22286090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum.
    Tang JX; Wen Q; Bennett A; Kim B; Sheils CA; Bucki R; Janmey PA
    Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L599-605. PubMed ID: 15964901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.
    Niemirowicz K; Surel U; Wilczewska AZ; Mystkowska J; Piktel E; Gu X; Namiot Z; Kułakowska A; Savage PB; Bucki R
    J Nanobiotechnology; 2015 May; 13():32. PubMed ID: 25929281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
    Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
    Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum.
    Bucki R; Byfield FJ; Janmey PA
    Eur Respir J; 2007 Apr; 29(4):624-32. PubMed ID: 17215317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the efficacy of erythromycin in multiple antibiotic-resistant gram-negative bacterial pathogens.
    Saha S; Savage PB; Bal M
    J Appl Microbiol; 2008 Sep; 105(3):822-8. PubMed ID: 18452533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
    Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ
    J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceragenins: cholic acid-based mimics of antimicrobial peptides.
    Lai XZ; Feng Y; Pollard J; Chin JN; Rybak MJ; Bucki R; Epand RF; Epand RM; Savage PB
    Acc Chem Res; 2008 Oct; 41(10):1233-40. PubMed ID: 18616297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.